CME Group Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CME Group Inc. on September 9, 2026. The filing addresses Item 5.02 regarding the departure of directors or certain officers and the appointment of new senior leadership within the finance and legal divisions.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change is the restructuring of senior finance leadership effective November 2, 2026:
- Jack Tobin: Appointed Managing Director, Deputy Chief Financial Officer. He will assume the role of Chief Financial Officer in March 2027, coinciding with Lynne Fitzpatrick's transition to Chief Executive Officer. Mr. Tobin had previously communicated plans to retire on October 30, 2026, but will continue his tenure due to these leadership changes.
- Matthew Render: Appointed Managing Director, Chief Accounting Officer, succeeding Mr. Tobin. Mr. Render joined CME Group in August 2026 from Citadel and Citadel Securities.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. It notes that Mr. Tobin and Mr. Render will participate in the Company's compensation program on terms available to similarly situated executive officers. No unusual items or compensatory arrangements requiring specific disclosure under Item 404(a) of Regulation S-K were identified for Mr. Render.
Investor Verification Checklist
- Verify the effective dates for Jack Tobin's promotion to Deputy CFO (November 2, 2026) and CFO (March 2027).
- Confirm the transition timeline for Lynne Fitzpatrick moving from CFO to CEO.
- Review the attached press release (Exhibit 99.1) for additional details on leadership structure changes.
- Monitor future filings for the formal retirement announcement of Jack Tobin, which was previously scheduled for October 2026 but has been deferred.